23
Jan

European regulators are recommending approval for The Medicines Company’s cangrelor, setting up an overseas nod for a blood-thinning drug rejected by the FDA last year.

…read more

Source: The Medicines Co.’s FDA-rejected cardio drug finds EU success

    

0 No comments